Express Scripts Holding Current Ratio 2006-2018 | ESRX

Current and historical current ratio for Express Scripts Holding (ESRX) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Express Scripts Holding current ratio for the three months ending June 30, 2018 was 0.71.
Express Scripts Holding Annual Current Ratio
2017 0.67
2016 0.75
2015 0.70
2014 0.62
2013 0.64
2012 0.82
2011 1.48
2010 0.75
2009 0.76
2008 0.75
2007 0.80
2006 0.73
2005 0.94
Express Scripts Holding Quarterly Current Ratio
Q2 2018 0.71
Q1 2018 0.69
Q4 2017 0.67
Q3 2017 0.73
Q2 2017 0.69
Q1 2017 0.71
Q4 2016 0.75
Q3 2016 0.70
Q2 2016 0.56
Q1 2016 0.60
Q4 2015 0.70
Q3 2015 0.64
Q2 2015 0.61
Q1 2015 0.62
Q4 2014 0.62
Q3 2014 0.61
Q2 2014 0.65
Q1 2014 0.60
Q4 2013 0.64
Q3 2013 0.82
Q2 2013 0.78
Q1 2013 0.76
Q4 2012 0.82
Q3 2012 0.80
Q2 2012 0.75
Q1 2012 2.14
Q4 2011 1.48
Q3 2011 0.64
Q2 2011 0.57
Q1 2011 0.85
Q4 2010 0.75
Q3 2010 0.64
Q2 2010 0.78
Q1 2010 0.78
Q4 2009 0.76
Q3 2009 2.21
Q2 2009 2.21
Q1 2009 0.79
Q4 2008 0.75
Q3 2008 0.70
Q2 2008 0.72
Q1 2008 0.81
Q4 2007 0.80
Q3 2007 0.71
Q2 2007 0.75
Q1 2007 0.77
Q4 2006 0.73
Q3 2006 0.74
Q2 2006 0.85
Q1 2006 1.00
Q4 2005 0.94
Q3 2005 0.86
Q2 2005 0.91
Q1 2005 0.85
Sector Industry Market Cap Revenue
Medical Medical Services $53.199B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.940B 25.71
PRA Health Sciences (PRAH) United States $6.922B 30.20
Charles River Laboratories (CRL) United States $6.141B 22.43
HealthEquity (HQY) United States $5.731B 119.95
Premier (PINC) United States $5.690B 20.50
Teladoc (TDOC) United States $5.247B 0.00
INC Research Holdings (SYNH) United States $4.913B 21.80
NovoCure (NVCR) Jersey $4.831B 0.00
AMN Healthcare Services Inc (AMN) United States $2.408B 18.50
Medpace Holdings (MEDP) United States $2.052B 28.84
BioTelemetry (BEAT) United States $1.976B 45.30
Intrexon (XON) United States $1.855B 0.00
Natera (NTRA) United States $1.432B 0.00
Healthways (TVTY) United States $1.348B 19.04
IKang Healthcare (KANG) China $1.167B 64.65
CareDx (CDNA) United States $0.940B 0.00
China Cord Blood (CO) China $0.785B 21.00
Surgery Partners (SGRY) United States $0.768B 0.00
Apollo Medical Holdings (AMEH) United States $0.547B 0.00
Civitas Solutions (CIVI) United States $0.525B 10.36
Establishment Labs Holdings (ESTA) $0.491B 0.00
OncoCyte (OCX) United States $0.098B 0.00
Interpace Diagnostics (IDXG) United States $0.047B 0.00
Cancer Genetics (CGIX) United States $0.030B 0.00
OpGen (OPGN) United States $0.012B 0.00
Biocept (BIOC) United States $0.007B 0.00
FORM Holdings (XSPA) United States $0.004B 0.00